Connect with us


CIA Warned Employees In March Against Hydroxychloroquine, While Some COVID Patients Say It Saved Their Lives



According to the Washington Post, the CIA privately advised its workforce that taking an anti-malarial drug hydroxychloroquine to treat Coronavirus has potentially dangerous side effects, including possible sudden death.

The warning came in late March in an internal CIA website and was in response to questions from employees at the time. While some medical experts say there isn’t conclusive evidence that hydroxychloroquine, administered along with the antibiotic azithromycin, is an effective treatment against the virus, numerous critical patients and treatments by physicians overseas and in the United States say otherwise. Their testimony has led to ongoing clinical trials in the United States and overseas to test the effectiveness of novel coronavirus.

President Donald Trump has touted the anti-malarial drug during his daily press briefings, saying that people infected with the coronavirus must be given options in their battle against COVID19. He also lambasted critics, saying critically ill patients deserve the right to try the therapeutic medicine in fighting the disease.

“I’m not looking at it one way or the other,” Trump said during a daily briefing. “But we want to get out of this. If it does work, it would be a shame if we didn’t do it early. But we have some very good signs.”

More than 23,000 people in the United States have died of the virus but recent statistics reveal that there appears to be a flattening of the curve in some of the most effected states, such as New York and California.

For example, Michigan Democratic State Representative Karen Whitsett told Fox News host Laura Ingraham last week that hydroxychloroquine stopped her coronavirus symptoms “within a couple hours” and she credited President Trump for informing the public about the drug during his national press briefings.

Whitsett, who represents an area of Detroit, told Ingraham “I really want to say that you have to give this an opportunity. For me, it saved my life.”

The National Institute of Health, however, has started a clinical trial of hydroxychloroquine in April, for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19). The first participants for the clinical trials enrolled in Tennessee, at Vanderbilt University Medical Center, Nashville.

“The blinded, placebo-controlled randomized clinical trial aims to enroll more than 500 adults who are currently hospitalized with COVID-19 or in an emergency department with anticipated hospitalization,” stated the NIH. “All participants in the study will continue to receive clinical care as indicated for their condition. Those randomized to the experimental intervention will also receive hydroxychloroquine.”

“Effective therapies for COVID-19 are urgently needed,” stated James P. Kiley, director, Division of Lung Diseases, NHLBI in a press release.  “Hydroxychloroquine has showed promise in a lab setting against SARS-CoV-2, the virus that causes COVID-19 and preliminary reports suggest potential efficacy in small studies with patients. However, we really need clinical trial data to determine whether hydroxychloroquine is effective and safe in treating COVID-19.”

While some medical experts say there’s no conclusive evidence it does what Trump has suggested — underscores a recurring phenomenon in this administration, in which the President stakes out a very public, sometimes controversial position on a subject only to have agencies within the government chart a different, more cautious approach.

You may like

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Historic House Vote Expels Rep. George Santos Amidst Scandal



GettyImages 1824951906 scaled

In a turn of events, the House of Representatives made history on Friday with a vote to expel Rep. George Santos (R-N.Y.), marking the first such expulsion in over two decades. A moment fraught with gravity unfolded as Speaker Mike Johnson wielded his gavel to formalize Santos’ removal, setting a precedent in congressional annals.

Santos, indicted on 23 counts related to wire fraud, identity theft, and other charges, has not faced conviction but stands accused of misusing campaign funds for opulent purchases. The bipartisan vote, tallying 311 to 114, signaled robust support for expulsion, with a marginally higher number of Republicans opting to retain Santos.

Questions loomed as Speaker Johnson left the chamber, his silence leaving the fate of the ongoing government spending battle uncertain. According to reports from Fox News, Democratic Rep. Steny Hoyer emphasized the non-partisan nature of the decision, asserting that members concluded Santos had tarnished the House’s reputation and was unfit for representation.

Within the GOP, conflicting opinions emerged, with Rep. Darrell Issa arguing against expulsion, citing the presumption of innocence. The tight-lipped stance of the House Ethics Committee played a pivotal role in the deliberations.

Conversely, members of the New York Republican delegation, led by Rep. Marc Molinaro, asserted Santos’ commission of crimes, justifying expulsion based on a comprehensive investigation.

Santos himself predicted the outcome in an exclusive morning interview on “FOX & Friends.” This vote not only underlines the House’s rare use of expulsion powers but also sets a critical precedent in handling members facing severe legal challenges.

You may like

Continue Reading